Medicine for treating neurasthenia and preparation method of medicine

A neurasthenia and drug technology, applied in the field of neurology, can solve the problems of prolonged neurasthenia, poor curative effect, drug dependence, etc., and achieve the effects of strong analgesic effect, short course of treatment and quick effect.
CN109464451AActive Publication Date: 2019-03-15范崇桂

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
范崇桂
Publication Date
2019-03-15
Patent Text Reader

Abstract

The invention relates to the technical field of the neurology department, in particular to a medicine for treating neurasthenia. The medicine is prepared from components in percentage by mass as follows: 2%-4% of trimetozine, 1%-5% of midecamycin, 30%-40% of nabumetone, 15%-17% of taurine, 2%-6% of ketotifen, 23%-25% of catechol, 3%-5% of nicotinamide, 1%-3% of oleanolic acid, 1.5%-2.5% of quetiapine and 2.5%-11.5% of loxoprofen. The invention also discloses a preparation method of the medicine. The medicine comprises the steps as follows: step 1, preparing materials; step 2, drying and grinding the materials into powder; step 3, performing crushing treatment; step 4, preparing an ethanol solution; step 5, performing concentration and drying; step 6, extracting the medicine. The medicine can effectively improve organism functions and enhance immunity, has significant effects on the neurasthenia, has no toxic or side effects on the human body, can relieve anxiety and cognitive defect symptoms and has effects of clearing heat, reducing internal heat, regulating flow of vital energy and dredging collaterals.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of neurology, in particular to a medicine for treating neurasthenia and a preparation method thereof. Background technique

[0002] Neurasthenia is a relatively broad term, and currently usually includes some depression, anxiety disorders, tension headaches, insomnia, indigestion, etc. Neurasthenia refers to the phenomenon of mental excitability and mental fatigue due to long-term tension and pressure, often accompanied by emotional troubles, irritability, sleep disturbance, muscle tension pain, etc. These symptoms cannot be attributed to brain, physical diseases or other diseases. Mental diseases, symptoms are mild and severe, fluctuations are related to psychosocial factors, and the course of the disease is often protracted.

[0003] In terms of treatment, modern medicine advocates the use of psychotherapy on the one hand, and chemical drug treatment on the other hand. Chemical drugs have only symptomatic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More